Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trialTicagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00473-2/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_acc24&_hsenc=p2ANqtz--F1AVN0SJeofHlHQTu_BoRImpO8lX5WHXC2FIYmrYhKmhC3h0UjRYdI1SZdYz2DjQd3ryMrdk7XoHXcUL0ELEdEaZukA&_hsmi=301366407&utm_content=301366407&utm_source=hs_email